Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Structure Revealed by Mass Spectrometry Technique

By LabMedica International staff writers
Posted on 31 May 2011
An advanced mass spectroscopy technique was used to detail the structure of a signaling protein critical to physiological processes involved in major diseases such as diabetes and cancer.

The protein, Epac2 (exchange protein directly activated by cAMP 2), is a guanine nucleotide exchange factor that regulates a wide variety of intracellular processes in response to second messenger cAMP (cyclic adenosine monophosphate).

A collaborative project was carried out by investigators at the University of Texas Medical Branch (Galveston, USA) and the University of California, San Diego (USA) to define the three-dimensional structure of Epac2 in the presence and absence of cAMP using an advanced mass spectroscopy technique known as hydrogen/deuterium exchange mass spectrometry (DXMS).

Results published in the May 20, 2011, issue of the Journal of Biological Chemistry revealed that that cAMP interacted with its two known binding sites on Epac2 in a sequential fashion and that binding of cAMP changed the shape of the protein in a very specific way. More...
This shape change was caused by a major hinge motion centered on the C- terminus of the second cAMP binding domain. This conformational change realigned the regulatory components of Epac2 away from the catalytic core, making the later available for effector binding.

"This study applied a powerful protein structural analysis approach to investigate how a chemical signal called cAMP turns on one of its protein switches, Epac2," said senior author Dr. Xiaodong Cheng, professor of pharmacology and toxicology at the University of Texas Medical Branch.

"DXMS analysis has proved to be an amazingly powerful approach, alone or in combination with other techniques, in figuring out how proteins work as molecular machines, changing their shapes – or morphing – in the normal course of their function," said contributing author Dr. Virgil Woods, professor of medicine at the University of California, San Diego. "This will be of great use in the identification and development of therapeutic drugs that target these protein motions."

Related Links:
University of Texas Medical Branch
University of California, San Diego




Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.